Depression in patients with peripheral arterial disease: A systematic review

European Journal of Cardiovascular Nursing

Volumn 16, Issue 3, 2017, Pages 181-193

  Brostow, Diana P ^a   Petrik, Megan L ^b,c   Starosta, Amy J ^b,d   Waldo, Stephen W ^a  

^a VA Eastern Colorado Healthcare System   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Depression; peripheral arterial disease; peripheral vascular diseases; review

Indexed keywords

CORONARY ARTERY DISEASE; DEPRESSION; DISEASE COURSE; GENETIC HETEROGENEITY; HUMAN; LOWER EXTREMITY FUNCTIONAL SCALE; MEDICATION COMPLIANCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING CESSATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WALKING DIFFICULTY; ADULT; AGED; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS;

EID: 85012072411     PISSN: 14745151     EISSN: 18731953     Source Type: Journal    
DOI: 10.1177/1474515116687222     Document Type: Review

References (77)

1. Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: Findings from the global burden of disease study 2010. PLoS Med 2013; 10: e1001547.
2. Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: Findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1575-1586.
3. Hare DL, Toukhsati SR, Johansson P, et al. Depression and cardiovascular disease: A clinical review. Eur Heart J 2014; 35: 1365-1372.
4. Lichtman JH, Bigger JT, Blumenthal JA, et al. AHA science advisory. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association Prevention Committee to the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care Outcomes Research. Endorsed by the American Psychiatric Association. Prog Cardiovasc Nurs 2009; 24: 19-26.
5. Fowkes FGR, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013; 382: 1329-1340.
6. Rooke TW, Hirsch AT, Misra S, et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61: 1555-1570.
7. Haschke A, Hutter N, Baumeister H,. Indirect costs in patients with coronary artery disease and mental disorders: A systematic review and meta-analysis. Int J Occup Med Environ Health 2012; 25: 319-329.
8. Damen NL, Versteeg H, Boersma E, et al. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: Results from the RESEARCH registry. Int J Cardiol 2013; 167: 2496-2501.
9. Rice TW, Lumsden AB,. Optimal medical management of peripheral arterial disease. Vasc Endovasc Surg 2006; 40: 312-327.
10. Hirsch AT, Murphy TP, Lovell MB, et al. Gaps in public knowledge of peripheral arterial disease: The first national PAD public awareness survey. Circulation 2007; 116: 2086-2094.
11. McDermott MM, Mehta S, Ahn H, et al. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997; 12: 209-215.
12. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 2009; 62: e1-e34.
13. Zeng X, Zhang Y, Kwong JSW, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: A systematic review. J Evid-Based Med 2015; 8: 2-10.
14. Cook DA, Reed DA,. Appraising the quality of medical education research methods: The Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education. J Assoc Am Med Coll 2015; 90: 1067-1076.
15. Columbo JA, Stone DH, Goodney PP, et al. The prevalence and regional variation of major depressive disorder among patients with peripheral arterial disease in the Medicare population. Vasc Endovascular Surg 2016; 50: 235-240.
16. Tully PJ, Baune BT,. Comorbid anxiety disorders alter the association between cardiovascular diseases and depression: The German National Health Interview and Examination Survey. Soc Psychiatry Psychiatr Epidemiol 2014; 49: 683-691.
17. Grenon SM, Cohen BE, Smolderen K, et al. Peripheral arterial disease, gender, and depression in the Heart and Soul Study. J Vasc Surg 2014; 60: 396-403.
18. Shankman SA, Nadelson J, McGowan SK, et al. The predictive power of depression screening procedures for veterans with coronary artery disease. Vasc Health Risk Manag 2012; 8: 233-238.
19. Poongothai S, Anjana RM, Pradeepa R, et al. Association of depression with complications of type 2 diabetes-the Chennai Urban Rural Epidemiology Study (CURES-102). J Assoc Physicians India 2011; 59: 644-648.
20. Baune BT, Unwin SJ, Quirk F, et al. Neuropsychiatric symptoms in patients with aortic aneurysms. PloS One 2011; 6: e22632.
21. Smolderen KG, Hoeks SE, Pedersen SS, et al. Lower-leg symptoms in peripheral arterial disease are associated with anxiety, depression, and anhedonia. Vasc Med 2009; 14: 297-304.
22. Wong SYS, Woo J, Hong AWL, et al. Clinically relevant depressive symptoms and peripheral arterial disease in elderly men and women. Results from a large cohort study in Southern China. J Psychosom Res 2007; 63: 471-476.
23. Bruce DG, Casey G, Davis WA, et al. Vascular depression in older people with diabetes. Diabetologia 2006; 49: 2828-2836.
24. Tiemeier H, van Dijck W, Hofman A, et al. Relationship between atherosclerosis and late-life depression: The Rotterdam study. Arch Gen Psychiatry 2004; 61: 369-376.
25. McDermott MM, Greenland P, Guralnik JM, et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med 2003; 18: 461-467.
26. Arseven A, Guralnik JM, O'Brien E, et al. Peripheral arterial disease and depressed mood in older men and women. Vasc Med 2001; 6: 229-234.
27. McDermott MM, Guralnik JM, Tian L, et al. Incidence and prognostic significance of depressive symptoms in peripheral artery disease. J Am Heart Assoc 2016; 4: e002959.
28. Chang P, Nead KT, Olin JW, et al. Clinical and socioeconomic factors associated with unrecognized peripheral artery disease. Vasc Med 2014; 19: 289-296.
29. Stauber S, Guéra V, Barth J, et al. Psychosocial outcome in cardiovascular rehabilitation of peripheral artery disease and coronary artery disease patients. Vasc Med 2013; 18: 257-262.
30. Siennicki-Lantz A, André-Petersson L, Wollmer P, et al. Depressive symptoms, atherosclerotic burden and cerebral blood flow disturbances in a cohort of octogenarian men from a general population. BMC Psychiatry 2013; 13: 347.
31. Grenon SM, Hiramoto J, Smolderen KG, et al. Association between depression and peripheral artery disease: Insights from the heart and soul study. J Am Heart Assoc 2012; 1: e002667.
32. Almeida OP, Alfonso H, Flicker L, et al. Cardiovascular disease, depression and mortality: The Health In Men Study. Am J Geriatr Psychiatry 2012; 20: 433-440.
33. Smolderen KG, Safley DM, House JA, et al. Percutaneous transluminal angioplasty: Association between depressive symptoms and diminished health status benefits. Vasc Med 2011; 16: 260-266.
34. Slovacek L, Slovackova B,. Artery balloon angioplasty and depression symptoms. Coll Antropol 2011; 35: 615-618.
35. Smolderen KG, Spertus JA, Vriens PW, et al. Younger women with symptomatic peripheral arterial disease are at increased risk of depressive symptoms. J Vasc Surg 2010; 52: 637-644.
36. Newson RS, Hek K, Luijendijk HJ, et al. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry 2010; 67: 1144-1151.
37. Smolderen KG, Aquarius AE, de Vries J, et al. Depressive symptoms in peripheral arterial disease: A follow-up study on prevalence, stability, and risk factors. J Affect Disord 2008; 110: 27-35.
38. Cherr GS, Zimmerman PM, Wang J, et al. Patients with depression are at increased risk for secondary cardiovascular events after lower extremity revascularization. J Gen Intern Med 2008; 23: 629-634.
39. Ruo B, Liu K, Tian L, et al. Persistent depressive symptoms and functional decline among patients with peripheral arterial disease. Psychosom Med 2007; 69: 415-424.
40. Cherr GS, Wang J, Zimmerman PM, et al. Depression is associated with worse patency and recurrent leg symptoms after lower extremity revascularization. J Vasc Surg 2007; 45: 744-750.
41. Aquarius AE, Denollet J, Hamming JF, et al. Type-D personality and ankle brachial index as predictors of impaired quality of life and depressive symptoms in peripheral arterial disease. Arch Surg 2007; 142: 662-667.
42. Wattanakit K, Williams JE, Schreiner PJ, et al. Association of anger proneness, depression and low social support with peripheral arterial disease: The Atherosclerosis Risk in Communities Study. Vasc Med 2005; 10: 199-206.
43. Musselman DL, Evans DL, Nemeroff CB,. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55: 580-592.
44. McManus D, Pipkin SS, Whooley MA,. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol 2005; 96: 1076-1081.
45. Ceccarini M, Manzoni GM, Castelnuovo G,. Assessing depression in cardiac patients: What measures should be considered? Depress Res Treat 2014; 2014: 148256.
46. First MB, Williams JBW, Karg RS, et al. Structured clinical interview for DSM-5-clinical version (SCID-5 for DSM-5, clinical version; SCID-5-CV, version 1.0.0). Arlington: American Psychiatric Association, 2015.
47. Krebber AMH, Buffart LM, Kleijn G, et al. Prevalence of depression in cancer patients: A meta-analysis of diagnostic interviews and self-report instruments. Psychooncology 2014; 23: 121-130.
48. McDermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment. JAMA 2001; 286: 1599-1606.
49. McDermott MM, Guralnik JM, Tian L, et al. Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: The WALCS (Walking and Leg Circulation Study). J Am Coll Cardiol 2009; 53: 1056-1062.
50. McDermott MM, Liu K, Greenland P, et al. Functional decline in peripheral arterial disease: Associations with the ankle brachial index and leg symptoms. JAMA 2004; 292: 453-461.
51. Penninx BW, Guralnik JM, Ferrucci L, et al. Depressive symptoms and physical decline in community-dwelling older persons. JAMA 1998; 279: 1720-1726.
52. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007; 45: S5-S67.
53. Safley DM, House JA, Laster SB, et al. Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization. Circulation 2007; 115: 569-575.
54. Stoner MC, Defreitas DJ, Manwaring MM, et al. Cost per day of patency: Understanding the impact of patency and reintervention in a sustainable model of healthcare. J Vasc Surg 2008; 48: 1489-1496.
55. Dempe C, Jünger J, Hoppe S, et al. Association of anxious and depressive symptoms with medication nonadherence in patients with stable coronary artery disease. J Psychosom Res 2013; 74: 122-127.
56. Parmenter BJ, Dieberg G, Phipps G, et al. Exercise training for health-related quality of life in peripheral artery disease: A systematic review and meta-analysis. Vasc Med 2015; 20: 30-40.
57. Armstrong EJ, Wu J, Singh GD, et al. Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease. J Vasc Surg 2014; 60: 1565-1571.
58. Doyle F, Rohde D, Rutkowska A, et al. Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with coronary heart disease: 1990 To 2013. Psychosom Med 2014; 76: 44-57.
59. Whooley MA, de Jonge P, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379-2388.
60. Ziegelstein RC, Fauerbach JA, Stevens SS, et al. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000; 160: 1818-1823.
61. Sigvant B, Wiberg-Hedman K, Bergqvist D, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg 2007; 45: 1185-1191.
62. Aboyans V, McClelland RL, Allison MA, et al. Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2011; 214: 169-173.
63. Ferrari AJ, Charlson FJ, Norman RE, et al. The epidemiological modelling of major depressive disorder: Application for the Global Burden of Disease Study 2010. PloS One 2013; 8: e69637.
64. Lavretsky H, Kumar A,. Clinically significant non-major depression: Old concepts, new insights. Am J Geriatr Psychiatry 2002; 10: 239-255.
65. Zung WW, Richards CB, Short MJ,. Self-rating depression scale in an outpatient clinic. Further validation of the SDS. Arch Gen Psychiatry 1965; 13: 508-515.
66. Centers for Disease Control and Prevention (CDC). Current depression among adults-United States, 2006 and 2008. MMWR Morb Mortal Wkly Rep 2010; 59: 1229-1235.
67. Hoel AW, Kayssi A, Brahmanandam S, et al. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials. J Vasc Surg 2009; 50: 349-354.
68. Garnefski N, Kraaij V, Wijers E, et al. Effects of a cognitive-behavioral self-help program on depressed mood for people with peripheral arterial disease. J Clin Psychol Med Settings 2013; 20: 186-191.
69. Huffman JC, Mastromauro CA, Sowden G, et al. Impact of a depression care management program for hospitalized cardiac patients. Circ Cardiovasc Qual Outcomes 2011; 4: 198-205.
70. Huffman JC, Mastromauro CA, Beach SR, et al. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: The Management of Sadness and Anxiety in Cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med 2014; 174: 927-935.
71. Brosig C, Yang K, Hoffmann RG, et al. The role of psychology in a pediatric outpatient cardiology setting: Preliminary results from a new clinical program. J Clin Psychol Med Settings 2014; 21: 337-346.
72. Linden W, Phillips MJ, Leclerc J,. Psychological treatment of cardiac patients: A meta-analysis. Eur Heart J 2007; 28: 2972-2984.
73. Treat-Jacobson D, Halverson SL, Ratchford A, et al. A patient-derived perspective of health-related quality of life with peripheral arterial disease. J Nurs Scholarsh 2002; 34: 55-60.
74. Lau-Walker MO, Cowie MR, Roughton M,. Coronary heart disease patients' perception of their symptoms and sense of control are associated with their quality of life three years following hospital discharge. J Clin Nurs 2009; 18: 63-71.
75. Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053-2061.
76. Tully PJ, Cosh SM,. Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: A meta-analysis. J Health Psychol. 2013; 18: 1601-1616.
77. Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004; 351: 13-22.